For its fourth fiscal quarter (ending December 31), Biolife Solutions Inc (NASDAQ: BLFS) has reported E.P.S. of $-0.30 compared to $-1.15 a year ago. This performance was $-0.03 short of the consensus estimate of $-0.27. E.P.S. were $-1.52 for the latest four quarters through December 31 versus $-3.29 for the same period a year ago.
Recent Price Action
Biolife Solutions Inc (NASDAQ: BLFS) stock declined modestly by -1.2% on 2/29/24. The stock closed at $16.90. NORMAL trading volume accompanied the decline. The stock has been weak relative to the market over the last nine months and has declined -3.4% during the last week.
Current PriceTarget Research Rating
BLFS’ future returns on capital are forecasted to be below the cost of capital. Accordingly, the company is expected to continue to be a modest Value Eraser.
Biolife Solutions has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing consistent signals. Biolife Solutions has a slightly negative Appreciation Score of 34 and a poor Power Rating of 26, and the Lowest Value Trend Rating results.
Rating Review
In light of this new information we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment